0.015062
0.000000
0.000000
0.000000
0.015062
0.000000
0.000000
0.000000
0.014548
0.00000
0.00000
0.00000
Moncalian, G.
Cardenes, N.
Deribe, Y.L.
Spinola-Amilibia, M.
Dikic, I.
Bravo, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
66.391
66.391
68.736
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
281
38845
10.1074/JBC.M606411200
17020880
Atypical Polyproline Recognition by the Cms N-Terminal SH3 Domain.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
110.0
1
MIRRORS
CCD
2004-06-07
MARRESEARCH
SINGLE WAVELENGTH
M
x-ray
1
1.54179
1.0
1.54179
ROTATING ANODE
ENRAF-NONIUS FR591
7412.285
CD2-ASSOCIATED PROTEIN
SH3 DOMAIN, RESIDUES 1-62
1
man
polymer
1119.382
T-CELL SURFACE ANTIGEN CD2
CMS BINDING SEQUENCE, RESIDUES 324-333
1
syn
polymer
18.015
water
46
nat
water
CAS LIGAND WITH MULTIPLE SH3 DOMAINS, ADAPTER PROTEIN CMS, CMS
T-CELL SURFACE ANTIGEN T11/LEU-5, LFA-2, LFA-3 RECEPTOR, ERYTHROCYTE RECEPTOR, ROSETTE RECEPTOR, CD2
no
no
MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETE
MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETE
A
polypeptide(L)
no
no
KGPPLPRPRV
KGPPLPRPRV
C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
469008
ESCHERICHIA COLI
BL21(DE3)
PET21
1
2.34
47.42
5.50
20% PEG3000, 0.1M ACETATE PH 5.5
diffrn_source
repository
Initial release
Version format compliance
Version format compliance
Data collection
1
0
2006-10-11
1
1
2011-05-08
1
2
2011-07-13
1
3
2017-07-05
_diffrn_source.type
N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2
CD2 (HUMAN)
CD2BP2-GYF DOMAIN IN COMPLEX WITH PROLINE- RICH CD2 TAILSEGMENT PEPTIDE
N-TERMINAL SH3 DOMAIN OF CIN85 BOUND TO CBL-B PEPTIDE
N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG) BOUND TO CBL-B PEPTIDE
N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG)
ATYPICAL POLYPROLINE RECOGNITION BY THE CMS N-TERMINAL SH3 DOMAIN.CMS:CD2 HETERODIMER
PDBE
Y
PDBE
2006-10-02
REL
HOH
water
9606
HUMAN
HOMO SAPIENS
sample
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2001
3
HOH
HOH
2001
C
HOH
2002
3
HOH
HOH
2002
C
n
1
1
A
VAL
2
n
2
VAL
2
A
ASP
3
n
3
ASP
3
A
TYR
4
n
4
TYR
4
A
ILE
5
n
5
ILE
5
A
VAL
6
n
6
VAL
6
A
GLU
7
n
7
GLU
7
A
TYR
8
n
8
TYR
8
A
ASP
9
n
9
ASP
9
A
TYR
10
n
10
TYR
10
A
ASP
11
n
11
ASP
11
A
ALA
12
n
12
ALA
12
A
VAL
13
n
13
VAL
13
A
HIS
14
n
14
HIS
14
A
ASP
15
n
15
ASP
15
A
ASP
16
n
16
ASP
16
A
GLU
17
n
17
GLU
17
A
LEU
18
n
18
LEU
18
A
THR
19
n
19
THR
19
A
ILE
20
n
20
ILE
20
A
ARG
21
n
21
ARG
21
A
VAL
22
n
22
VAL
22
A
GLY
23
n
23
GLY
23
A
GLU
24
n
24
GLU
24
A
ILE
25
n
25
ILE
25
A
ILE
26
n
26
ILE
26
A
ARG
27
n
27
ARG
27
A
ASN
28
n
28
ASN
28
A
VAL
29
n
29
VAL
29
A
LYS
30
n
30
LYS
30
A
LYS
31
n
31
LYS
31
A
LEU
32
n
32
LEU
32
A
GLN
33
n
33
GLN
33
A
GLU
34
n
34
GLU
34
A
GLU
35
n
35
GLU
35
A
GLY
36
n
36
GLY
36
A
TRP
37
n
37
TRP
37
A
LEU
38
n
38
LEU
38
A
GLU
39
n
39
GLU
39
A
GLY
40
n
40
GLY
40
A
GLU
41
n
41
GLU
41
A
LEU
42
n
42
LEU
42
A
ASN
43
n
43
ASN
43
A
GLY
44
n
44
GLY
44
A
ARG
45
n
45
ARG
45
A
ARG
46
n
46
ARG
46
A
GLY
47
n
47
GLY
47
A
MET
48
n
48
MET
48
A
PHE
49
n
49
PHE
49
A
PRO
50
n
50
PRO
50
A
ASP
51
n
51
ASP
51
A
ASN
52
n
52
ASN
52
A
PHE
53
n
53
PHE
53
A
VAL
54
n
54
VAL
54
A
LYS
55
n
55
LYS
55
A
GLU
56
n
56
GLU
56
A
ILE
57
n
57
ILE
57
A
LYS
58
n
58
LYS
58
A
n
59
59
A
n
60
60
A
n
61
61
A
n
62
62
A
n
1
324
C
n
2
325
C
n
3
326
C
PRO
327
n
4
PRO
327
C
LEU
328
n
5
LEU
328
C
PRO
329
n
6
PRO
329
C
ARG
330
n
7
ARG
330
C
PRO
331
n
8
PRO
331
C
ARG
332
n
9
ARG
332
C
VAL
333
n
10
VAL
333
C
author_and_software_defined_assembly
PQS
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
PHE
49
A
N
PHE
49
A
O
LEU
38
A
O
LEU
38
A
N
GLU
41
A
N
GLU
41
A
O
ARG
27
A
O
ARG
27
A
N
ILE
26
A
N
ILE
26
A
O
TYR
4
A
O
TYR
4
A
N
ILE
5
A
N
ILE
5
A
O
LYS
55
A
O
LYS
55
1
A
HOH
2002
C
HOH
1
A
MET
1
A
MET
1
1
Y
1
A
ARG
59
A
ARG
59
1
Y
1
A
GLU
60
A
GLU
60
1
Y
1
A
THR
61
A
THR
61
1
Y
1
A
GLU
62
A
GLU
62
1
Y
1
C
LYS
324
B
LYS
1
1
Y
1
C
GLY
325
B
GLY
2
1
Y
1
C
PRO
326
B
PRO
3
1
Y
1
3.01
0.50
120.30
123.31
C
C
C
NE
CZ
NH1
ARG
ARG
ARG
330
330
330
N
1
C
C
CZ
NH1
ARG
ARG
330
330
0.089
0.013
1.326
1.415
N
1
A
VAL
22
-38.12
124.98
1
A
GLU
34
-52.31
108.81
1
C
PRO
329
-74.88
-167.43
24.85
-0.21000
0.00000
0.00000
-0.21000
0.00000
0.42000
0.907
0.891
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. THE BIOLOGICAL UNIT OF THIS STRUCTURE IS A HETEROTRIMER CONSISTING OF TWO CMS SH3A DOMAINS AND ONE CD2 PEPTIDE IN TWO ORIENTATIONS, WITH 0.5 OCCUPANCY EACH. THE SECOND CMS SH3A MOLECULES, AS WELL AS THE SECOND ORIENTATION OF THE PEPTIDE, ARE RELATED TO THAT IN THE ASYMMETRIC UNIT BY A CRYSTALLOGRAPHIC SYMMETRY OPERATION.
0.286
0.241
0.243
2.23
47.73
177
3932
4.520
98.1
8.792
0.211
RANDOM
1
THROUGHOUT
0.000
MOLECULAR REPLACEMENT
0.361
0.259
0.80
0.80
1.40
CMSA-CBL-B STRUCTURE
MAXIMUM LIKELIHOOD
BABINET MODEL PLUS MASK
2.23
47.73
46
580
0
0
534
0.010
0.022
562
1.306
1.974
762
5.750
5.000
68
29.944
24.062
32
16.883
15.000
104
17.052
15.000
6
0.077
0.200
82
0.004
0.020
432
0.201
0.200
220
0.304
0.200
353
0.172
0.200
33
0.256
0.200
31
0.196
0.200
10
1.482
3.000
335
2.310
4.000
534
2.058
4.000
254
3.007
6.000
225
0.3390
0.4050
47.73
3
59
20
33.00
2.220
34.360
2J6O
3933
0.000
0.11000
1
25.0200
16.660
98.0
0.41000
2.22
2.26
15.740
1
14.22
86.6
refinement
REFMAC
5.2.0019
data reduction
MOSFLM
data scaling
TRUNCATE
phasing
AMoRE
CD2-ASSOCIATED PROTEIN, T-CELL SURFACE ANTIGEN CD2
ATYPICAL POLYPROLINE RECOGNITION BY THE CMS N-TERMINAL SH3 DOMAIN. CMS:CD2 HETEROTRIMER
1
N
N
2
N
N
3
N
N
3
N
N
A
ASP
51
A
ASP
51
HELX_P
A
PHE
53
A
PHE
53
5
1
3
PROTEIN BINDING
PHOSPHORYLATION, ADAPTOR PROTEIN, EGFR DOWNREGULATION, CMS, SH3 DOMAIN, SH3-BINDING, COILED COIL, SH3 DOMAIN RECOGNITION, SIGNALING PROTEIN, PROTEIN BINDING
CD2AP_HUMAN
UNP
1
Q9Y5K6
CD2_HUMAN
UNP
2
P06729
1
62
2J6O
1
62
Q9Y5K6
A
1
1
62
324
333
2J6O
324
333
P06729
C
2
1
10
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ARG
45
A
ARG
45
A
PRO
50
A
PRO
50
A
TRP
37
A
TRP
37
A
LEU
42
A
LEU
42
A
ILE
25
A
ILE
25
A
LYS
31
A
LYS
31
A
TYR
4
A
TYR
4
A
VAL
6
A
VAL
6
A
VAL
54
A
VAL
54
A
GLU
56
A
GLU
56
97
I 4 2 2